Physicians' Academy for Cardiovascular Education

Cholesterol guidelines in need of major changes?

Expert Meeting on LDL-c & PCSK9 inhibition in high CV risk patients

5' education - Jan. 25, 2019 - Kausik Ray, François Mach

Video navigation menu

  • Why should the guidelines be changed? 00:17
  • How can we improve risk prediction? 01:50
  • What have been major game changers with respect to risk enhancers? 03:49

Educational information

This video was recorded during an expert meeting among cardiologists and internists, focussing on the topic of 'LDL-c & PCSK9 inhibition in high CV risk patients - Balancing Science, Guidelines and Daily Cardiology Practice'.

The objectives of the meeting were to:

Other topics covered in this series

Other lectures part of this educational series are:

Faculty

Prof. Kausik Ray, cardiologist, Imperial College London, United Kingdom

Prof. François Mach, cardiologist, University of Geneva, Switzerland

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

Funding for the Expert Meeting was provided by an unrestricted educational grant from Amgen. The sponsor did not attend and influence the video recording.

Share this page with your colleagues and friends: